Published in Cancer Weekly, March 25th, 2003
The Mayo Clinic finding is significant because the MDC1 gene appears to be closer than most others investigated so far to the earliest events that go wrong in a healthy body and cause cells to turn cancerous. Specifically, MDC1 is a "checkpoint protein" that appears to guard against abnormal cells reproducing themselves, a process that leads to cancers.
The Mayo Clinic results - along with those from the other laboratories in Cambridge, England, and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.